Letters
Open data
EFPIA-PhRMA’s principles for clinical trial data sharing have been misunderstood
BMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f5164 (Published 20 August 2013) Cite this as: BMJ 2013;347:f5164
- Peter Doshi, postdoctoral fellow1
- 1Johns Hopkins University, Baltimore, Maryland, USA
- pnd{at}jhu.edu
The recent joint statement of the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the Pharmaceutical Research and Manufacturers of America (PhRMA) of their principles for responsible sharing of clinical trial data1 has been misunderstood in two important ways, exaggerating the perceived progressiveness of the principles.
Firstly, despite reports that all member drug companies have agreed to set up independent or external review panels to judge third party requests for …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.